Matrix protein
Matrix protein 1 (229-237) is a synthetic peptide corresponding to amino acid residues 229 to 237 of the influenza A virus matrix protein 1 (M1). As a well-defined epitope, this peptide is widely recognized in virology and immunology research for its role in viral structure and host immune recognition. Its sequence is highly conserved among influenza A strains, making it a valuable reagent for studies focused on viral infection mechanisms and host-pathogen interactions. The defined nature and immunological relevance of this region have established it as a key tool in the investigation of T-cell responses, epitope mapping, and antigen presentation, supporting a broad range of experimental approaches in both basic and applied research.
Epitope mapping: The 229-237 region of matrix protein 1 serves as a prominent epitope for cytotoxic T lymphocyte (CTL) recognition in influenza research. By incorporating this peptide into immunological assays, researchers can precisely identify and characterize T-cell populations responsive to influenza infection. This facilitates the delineation of antigenic determinants involved in immune surveillance, advancing understanding of host adaptive immunity and informing the rational design of vaccines or immunotherapeutic strategies in preclinical settings.
Antigen presentation studies: The peptide is frequently utilized to investigate mechanisms of antigen processing and presentation by major histocompatibility complex (MHC) class I molecules. When loaded onto antigen-presenting cells, it enables controlled examination of peptide-MHC interactions, T-cell receptor specificity, and subsequent immune activation. Such studies are critical for elucidating the molecular basis of cellular immunity and for optimizing peptide-based vaccine candidates or immunological assays targeting viral infections.
Functional T-cell assays: Matrix protein 1 (229-237) is commonly employed in ex vivo and in vitro assays to stimulate and quantify influenza-specific CD8+ T-cell responses. Its use in enzyme-linked immunospot (ELISPOT), intracellular cytokine staining, and flow cytometry-based proliferation assays allows researchers to monitor effector functions such as cytokine production, cytolytic activity, and memory T-cell formation. These functional readouts provide comprehensive insights into the dynamics of cellular immune responses during infection or following immunization in animal models.
Peptide-based vaccine research: The well-characterized immunodominant properties of this peptide make it an ideal candidate for evaluation in peptide-based vaccine models. Studies often incorporate the 229-237 fragment to assess its potential to induce protective T-cell immunity in preclinical systems. The ability to elicit robust, specific CTL responses supports its use in comparative analyses of vaccine formulations, adjuvants, and delivery platforms, contributing to the refinement of next-generation antiviral vaccine strategies.
Structural and binding studies: The defined sequence and immunological relevance of the peptide enable its use in biophysical and structural investigations. Researchers utilize it to probe the binding interactions between peptide epitopes and MHC class I molecules through techniques such as X-ray crystallography, NMR spectroscopy, and surface plasmon resonance. These studies provide atomic-level insights into epitope conformation, stability, and recognition, advancing the structural biology of antigen presentation and informing rational immunogen design.
Through these diverse and scientifically validated applications, Matrix protein 1 (229-237) serves as a critical reagent for advancing research in viral immunology, epitope characterization, and the molecular mechanisms underlying host immune defense against influenza A virus. Its versatility and specificity make it an indispensable tool for laboratories focused on understanding and manipulating antigen-specific immune responses in experimental systems.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More